(VIANEWS) – United Therapeutics Corporation (UTHR), Realty Income Corporation (O), Axcelis Technologies (ACLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. United Therapeutics Corporation (UTHR)
17.1% sales growth and 16.86% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $15.52.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 14.64. Meaning, the purchaser of the share is investing $14.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.86%.
Sales Growth
United Therapeutics Corporation’s sales growth is 25.1% for the present quarter and 17.1% for the next.
2. Realty Income Corporation (O)
16.2% sales growth and 3.23% return on equity
Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.
Earnings Per Share
As for profitability, Realty Income Corporation has a trailing twelve months EPS of $1.42.
PE Ratio
Realty Income Corporation has a trailing twelve months price to earnings ratio of 43.22. Meaning, the purchaser of the share is investing $43.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.23%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Realty Income Corporation’s EBITDA is 73.89.
3. Axcelis Technologies (ACLS)
12.8% sales growth and 30.36% return on equity
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Earnings Per Share
As for profitability, Axcelis Technologies has a trailing twelve months EPS of $5.5.
PE Ratio
Axcelis Technologies has a trailing twelve months price to earnings ratio of 24.23. Meaning, the purchaser of the share is investing $24.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.36%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.3%, now sitting on 920M for the twelve trailing months.
4. South State Corporation (SSB)
11% sales growth and 10.04% return on equity
South State Corporation operates as the bank holding company for South State Bank that provides a range of banking services and products. The company accepts checking accounts, savings deposits, interest-bearing transaction accounts, certificates of deposits, and other time deposits. It also offers commercial real estate loans, residential real estate loans, commercial, and industrial loans, as well as consumer loans, including auto, boat, and personal installment loans. In addition, the company provides treasury management services, merchant services, debit card products, automated clearing house services, lock-box services, remote deposit capture services, and other treasury services. As of December 31, 2020, it served customers through 285 branches in Florida, South Carolina, Alabama, Georgia, North Carolina, and Virginia. The company was formerly known as First Financial Holdings, Inc. and changed its name to South State Corporation in July 2013. South State Corporation was founded in 1933 and is headquartered in Winter Haven, Florida.
Earnings Per Share
As for profitability, South State Corporation has a trailing twelve months EPS of $6.6.
PE Ratio
South State Corporation has a trailing twelve months price to earnings ratio of 10.64. Meaning, the purchaser of the share is investing $10.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.04%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 1.56B for the twelve trailing months.
Sales Growth
South State Corporation’s sales growth is 28.5% for the ongoing quarter and 11% for the next.
